# data[].attributes.headline
Scholarly articles concerning Suboxone use:

# data[].attributes.subject
Scholarly articles concerning Suboxone use:

# data[].attributes.body
1. http://substanceabusepolicy.biomedcentral.com/articles/10.1186/1747-597X-3-16
2. http://journals.lww.com/journaladdictionmedicine/Abstract/2007/06000/Two_year_Experience_with_Buprenorphine_naloxone.8.aspx

# data[].attributes.body
http://www.suboxone.com/medical-treatment

# data[].attributes.body
A holistic approach to medically monitored tapering.
https://www.alternativetomeds.com/

# data[].attributes.headline
Personal testimony of getting addicted to Suboxone 

# data[].attributes.subject
Personal testimony of getting addicted to Suboxone 

# data[].attributes.body
https://www.thefix.com/content/suboxone-addict-you-never-knew-existed

# data[].attributes.headline
Intended use - during maintenance process by those currently addicted to drugs

# data[].attributes.subject
Intended use - during maintenance process by those currently addicted to drugs

# data[].attributes.body
Buprenorphine = mu-opiod receptor partial agonist & kappa-opiod receptor antaonist. Simply put - mild opiate analgesic (pain reducer) with mixed opiate receptor activity.
Naloxone = opiod receptor antagonist. Simply put - eliminates or reverses effects of opiates and brings on withdrawl symptoms when other opiates are used.

# data[].attributes.body
http://www.wkyt.com/home/headlines/WKYT-Investigates--Authorities-say-Suboxone-could-be-Kentuckys-next-epidemic-325465711.html

# data[].attributes.body
SCHEDULE III DRUG

# data[].attributes.body
http://drugabuse.com/library/the-effects-of-suboxone-use/